United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $964,180,770.30
Most recent insider trade:
  • Feb. 25, 2026
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 7, 2015CEO2,211$126.04Sell$278,674.44
Jan. 6, 2015CEO7,500$124.93Sell$936,975.00
Jan. 6, 2015COO3,000$124.93Sell$374,790.00
Jan. 5, 2015CEO2,592$126.88Sell$328,872.96
Jan. 2, 2015Director3,000$129.25Sell$387,750.00
Jan. 2, 2015CEO9,662$126.53Sell$1,222,532.86
Jan. 2, 2015EVP6,000$127.73Sell$766,380.00
Dec. 31, 2014CEO2,211$131.35Sell$290,414.85
Dec. 30, 2014CEO10,000$130.80Sell$1,308,000.00
Dec. 29, 2014CEO2,592$131.75Sell$341,496.00
Dec. 26, 2014CEO9,662$131.85Sell$1,273,934.70
Dec. 24, 2014CEO2,211$130.35Sell$288,203.85
Dec. 23, 2014COO10,000$127.82Sell$1,278,200.00
Dec. 22, 2014CEO2,592$133.45Sell$345,902.40
Dec. 19, 2014Director1,500$131.47Sell$197,205.00
Dec. 18, 2014EVP10,750$130.03Sell$1,397,822.50
Dec. 18, 2014CFO10,000$131.11Sell$1,311,100.00
Dec. 18, 2014CEO9,662$129.06Sell$1,246,977.72
Dec. 17, 2014CEO2,211$126.04Sell$278,674.44
Dec. 15, 2014CEO2,592$129.75Sell$336,312.00
Dec. 11, 2014CEO9,662$130.98Sell$1,265,528.76
Dec. 10, 2014CEO2,211$132.77Sell$293,554.47
Dec. 9, 2014COO10,000$134.80Sell$1,348,000.00
Dec. 8, 2014CEO2,592$132.34Sell$343,025.28
Dec. 4, 2014Director3,000$131.58Sell$394,740.00
Dec. 4, 2014CEO11,873$131.32Sell$1,559,162.36
Dec. 4, 2014EVP11,000$129.92Sell$1,429,120.00
Dec. 4, 2014CFO10,000$129.05Sell$1,290,500.00
Dec. 2, 2014COO10,000$133.63Sell$1,336,300.00
Dec. 1, 2014CEO2,592$132.92Sell$344,528.64
Nov. 28, 2014CEO11,873$132.77Sell$1,576,378.21
Nov. 25, 2014COO10,000$131.30Sell$1,313,000.00
Nov. 24, 2014CEO2,592$130.72Sell$338,826.24
Nov. 21, 2014COO10,000$130.15Sell$1,301,500.00
Nov. 20, 2014CFO10,000$129.22Sell$1,292,200.00
Nov. 20, 2014CEO9,662$128.86Sell$1,245,045.32
Nov. 20, 2014Director1,500$127.20Sell$190,800.00
Nov. 20, 2014EVP11,000$129.02Sell$1,419,220.00
Nov. 19, 2014CEO2,211$128.69Sell$284,533.59
Nov. 18, 2014COO10,000$128.21Sell$1,282,100.00
Nov. 17, 2014CEO2,592$125.65Sell$325,684.80
Nov. 13, 2014CEO9,662$124.79Sell$1,205,720.98
Nov. 12, 2014CEO2,211$122.88Sell$271,687.68
Nov. 10, 2014CEO2,592$125.14Sell$324,362.88
Nov. 7, 2014Director5,000$124.49Sell$622,450.00
Nov. 7, 2014COO10,000$124.46Sell$1,244,600.00
Nov. 6, 2014EVP5,000$125.02Sell$625,100.00
Nov. 6, 2014CEO4,115$125.33Sell$515,732.95
Nov. 6, 2014Director1,500$122.89Sell$184,335.00
Nov. 5, 2014CEO2,211$124.31Sell$274,849.41
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Michael Benkowitz, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, Nilda Mesa, James Edgemond, Tommy G Thompson, Louis W Sullivan, Judy D Olian, Paul A. Mahon, Jan Malcolm, Ray Kurzweil, Tommy G. Thompson, MAHON PAUL A, Louis Sullivan, Judy D. Olian, R Paul Gray, and DWEK RAYMOND

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 393 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $386,981,200.91.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on Feb. 25, 2026.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $10,679,625.00 on Feb. 9, 2026.